Page tree
Skip to end of metadata
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 2 Current »

Date

July 31st, 2020 

Time

3:00pm - 3:45pm ET

Attendees

ACS CAN → Mark Fleury, Devon Adams, Kelly Durden 

MITRE → Salim Semy, Jennifer Holmes, Zach Lister, Rob Dingwell, Caroline Potteiger

Cancer Insights → Sharon Alford, Tarun Kumar 

Action items

  • Kelly → touch base with Robin about connection with the Grady Health System.  
  • Sharon → make the introduction between ZS Associates and this team. 
  • Caroline Potteiger → send Confluence permission information to the team.
  • All → brainstorm tasks for each Phase 1a bucket and send to Caroline. 


Discussion notes in blueDecisions in greenAction items in red.

Planned Agenda Topics

  • <Hold for hot topics from project team>
    • Mark will be out next week. 
  • Engagement Update
    • Epic – very interested, seemed willing to partner if we identify a health center for Phase 1
      • Epic can give feedback on the health center and if they have the ability to work well in this project.
      • For the grant ACS CAN is applying to, an ideal partner health system would be in a redline area. 
        • The Grady Health System in Atlanta is one they are looking at. They use Epic and ACS CAN has a lot of projects with them. 
        • Kelly will touch base with Robin to see where the connections with Grady are and if they're willing to partner if offered some money. 
      • Caroline will be sending out a list of health systems we are talking with to Epic. Leave Grady off the list for now, until contact is made on our end first. 
      • The fact that Epic is willing to partner on this use case is a compelling point for health systems to become involved.
      • As we iterate on the minimal eligibility criteria, Epic could add it to their system. 
    • TrialJectory – meeting scheduled for August 13th  
    • Massive Bio – willing to provide a handful of patient records, has to look into de-identification process more  
      • Seline offered to reach out to St. Charles. 
    • CitiusTech - has expressed interest
    • Elsevier - has expressed interest 
      • Elsevier has the ViaOncology Pathways tool and is looking at ways to bring matching capabilities into the tool. This could include a branch in the pathway for when it is time to start looking for clinical trials. 
      • They are discussing internally about this project.
      • Would act similar to an EHR.
    • Other updates? 
      • Flatiron - reached out to Mark and wants to learn more.
        • MITRE has been interacting with them on the Pathways and Prior Auth use cases. Make sure everyone is kept in the loop. 
      • Cancer Support Community - reached out and spoke to Mark.
        • They are an advocation group. Not a great fit at this time, no immediate next steps. 
      • NCI - expressed interest in learning more and would act as a matching service partner. 
        • However, NCI matching would only focus on NCI sponsored trials. 
      • BeTheMatch - couldn't find bandwidth to work on this project this year.  
      • UCSF - Elly, Adam, and Lisa will be speaking about a UCSF partnership in August. 
      • ZS Associates - Cancer Insights has worked with them. Sharon will make an introduction and see if there is an intersection between their work and ours.   
  • Phase 0 update
    • Mike gave us more administrative access, last step is to label the trials 
    • Add more trials? 
  • Phase 1 update
    • Planning in progress 
    • Caroline to showcase Private Confluence page as a way to collaborate 
      • Looks good for now. Caroline to send permission information to everyone so they can experiment with Confluence. 
  • Proposed tasks for Phase 1a 
    • Tarun and Caroline came up with some "buckets" of tasks for Phase 1a and a few sub-tasks under each bucket 
    • Review and add tasks? 
    • 1A Protocol and Pilot Process
      • Draft study protocol and IRB submission 
      • Process of de-identification 
      • Plan out recruitment of patients – Mark to help?
        • Create a 1-pager targeted towards patients?  
        • Are patients needed for this phase? Or just data?  
          • If it's just data, all we need is access.  
          • Option 1 - Cancer Insights patients can get their data and share it with us.
            • Would need a waiver of consent from the IRB to share this data. Must be de-identified. 
            • Problem is that patients are giving us data, but we're not really giving much back. 
          • Option 2 - find sources of existing data. 
            • BreastCancerTrials.org may have data we can use.  
            • Ciitizen - could be a source of data. Mark has spoken to them.
              • MITRE has also had discussions with Anil Sethi when this project was just beginning. We could revisit this. 
          • Option 3 - find volunteers willing to share data.
            • ACS CAN has a lot of volunteers who would most likely be willing to share data.
            • However, to use ACS CAN's name, there would be many internal hoops to jump through, which would take a lot of time.  
      • Plan out onboarding of patients 
      • Generate mCODE records for these patients 
    • PCT Technical Readiness for 1A
      • ?
    • Cancer Insights Integration 
      • Map Cancer Insights data model to generate mCODE 
      • Address gaps using FHIR Questionnaire 
      • Create an agnostic interface 
      • Integration with PCT component
    • Standards Documentation 
      • Adjust documentation to be more trial matching service agnostic and patient portal agnostic 
      • Develop a FHIR Implementation Guide for mCODE-enabling matching services
    • mCODE-enable Matching Services Suggestion: We may roll it into PCT Technical Readiness for 1A
      • Create Sandbox 
      • Map matching service to mCODE


  • No labels